Proposal 4. To authorize the Audit Committee of the Board of Directors to determine the compensation of the Company’s UK statutory auditor
| | | | |
For | | Against | | Abstain |
288,741,249 | | 114,161 | | 43,055 |
This proposal was approved.
Proposal 5. To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers as disclosed in the Proxy Statement
| | | | | | |
For | | Against | | Abstain | | Broker Non-Votes |
217,129,451 | | 26,216,759 | | 35,125,152 | | 10,427,103 |
This proposal was approved.
Proposal 6. To approve on a non-binding, advisory basis the Directors’ Compensation Report for the year ended December 31, 2021, which was included as Annex A in the Proxy Statement
| | | | | | |
For | | Against | | Abstain | | Broker Non-Votes |
223,488,103 | | 19,861,905 | | 35,121,354 | | 10,427,103 |
This proposal was approved.
Proposal 7. To authorize the Board of Directors to allot equity securities
| | | | |
For | | Against | | Abstain |
244,502,432 | | 44,360,402 | | 35,631 |
This proposal was approved.
Proposal 8. To authorize the Board of Directors to allot equity securities without rights of pre-emption
| | | | |
For | | Against | | Abstain |
248,466,119 | | 40,099,230 | | 333,116 |
This proposal was approved.
Proposal 9. To authorize the Board of Directors to allot equity securities without rights of pre-emption in connection with an acquisition or specified capital investment
| | | | |
For | | Against | | Abstain |
248,125,539 | | 40,442,354 | | 330,572 |
This proposal was approved.
Proposal 10. To approve of forms of share repurchase contracts and share repurchase counterparties
| | | | |
For | | Against | | Abstain |
285,546,995 | | 2,300,754 | | 1,050,716 |
This proposal was approved.